Legal Representation
Attorney
AMANDA LAURA NYE
USPTO Deadlines
Next Deadline
0 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
July 12, 2025
Application History
18 events| Date | Code | Type | Description |
|---|---|---|---|
| May 12, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| May 12, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Oct 8, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 13, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 13, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 2, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jul 2, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jul 2, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jul 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 2, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Apr 10, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 10, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Apr 10, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 31, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 5, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 4, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 20, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and compositions for the treatment and prevention of cancer; biological preparations for the treatment of cancer; pain relief preparations; anti-inflammatories; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; nutritional supplements
Class 036
Capital investment; financial investment brokerage services; financial investment analysis; investment consultancy; investment management; investment services, namely, capital investments, investment consultation; capital investment fund management; private equity fund management; venture capital funding of product development; providing venture capital funding for the development of new technology; venture capital funding services for emerging and start-up companies; venture capital funding services for research institutions
Class 042
Scientific research for medical purposes in the area of cancerous diseases
Class 044
Providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment
Additional Information
Design Mark
The mark consists of a fanciful design comprised of the capital letter "B", repeating three times and attached at the top of each letter "B" to form a circular design in the color blue. Centered underneath this design are the literal elements "3B FUTURE", with "3B" in blue and "FUTURE" in grey, above "Health Fund" in grey. The color white represents transparent area and is not part of the mark.
Color Claim
The color(s) blue and grey is/are claimed as a feature of the mark.
Pseudo Mark
BBB THREE B FUTURE HEALTH FUND
Classification
International Classes
005
036
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTH FUND"